{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:04:25Z","timestamp":1771488265543,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00330-021-08042-1","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T17:02:51Z","timestamp":1621962171000},"page":"9520-9528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic value of response evaluation based on breast MRI after neoadjuvant treatment: a retrospective cohort study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-9885","authenticated-orcid":false,"given":"Almir G. V.","family":"Bitencourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara S.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius F.","family":"Calsavara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M. S.","family":"Negr\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana A.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S.","family":"Guatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana B.","family":"Makdissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange M.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique C.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A. B. T.","family":"Os\u00f3rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"De Brot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira F.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubens","family":"Chojniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"8042_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J et al (2019) Breast cancer. Nat Rev Dis Primers 5:66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2","journal-title":"Nat Rev Dis Primers"},{"key":"8042_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment. JAMA 321:288. https:\/\/doi.org\/10.1001\/jama.2018.19323","journal-title":"JAMA"},{"key":"8042_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164\u2013172. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"8042_CR4","doi-asserted-by":"publisher","unstructured":"Rauch GM, Adrada BE, Kuerer HM, van la Parra RFD, Leung JWT, Yang WT (2017) Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol 208:290\u2013299. https:\/\/doi.org\/10.2214\/AJR.16.17223","DOI":"10.2214\/AJR.16.17223"},{"key":"8042_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1148\/radiol.2017170180","volume":"285","author":"AM Fowler","year":"2017","unstructured":"Fowler AM, Mankoff DA, Joe BN (2017) Imaging neoadjuvant therapy response in breast cancer. Radiology 285:358\u2013375. https:\/\/doi.org\/10.1148\/radiol.2017170180","journal-title":"Radiology"},{"key":"8042_CR6","doi-asserted-by":"publisher","unstructured":"Gu Y-L, Pan S-M, Ren J, Yang Z-X, Jiang G-Q (2017) Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis. Clin Breast Cancer 17:245\u2013255. https:\/\/doi.org\/10.1016\/j.clbc.2016.12.010","DOI":"10.1016\/j.clbc.2016.12.010"},{"key":"8042_CR7","doi-asserted-by":"publisher","unstructured":"Marinovich ML, Houssami N, Macaskill P et al (2013) Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst 105:321\u2013333. https:\/\/doi.org\/10.1093\/jnci\/djs528","DOI":"10.1093\/jnci\/djs528"},{"key":"8042_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.breast.2018.04.018","volume":"40","author":"H Li","year":"2018","unstructured":"Li H, Yao L, Jin P et al (2018) MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast 40:106\u2013115. https:\/\/doi.org\/10.1016\/j.breast.2018.04.018","journal-title":"Breast"},{"key":"8042_CR9","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"8042_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M et al (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update. J Clin Oncol 38:1346\u20131366. https:\/\/doi.org\/10.1200\/JCO.19.02309","journal-title":"J Clin Oncol"},{"key":"8042_CR11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/ College of American Pathologists Clinical Practice Guideline focused update. J Clin Oncol 36:2105\u20132122. https:\/\/doi.org\/10.1200\/JCO.2018.77.8738","journal-title":"J Clin Oncol"},{"key":"8042_CR12","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414\u20134422. https:\/\/doi.org\/10.1200\/JCO.2007.10.6823","journal-title":"J Clin Oncol"},{"key":"8042_CR13","volume-title":"ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System","author":"EA Morris","year":"2013","unstructured":"Morris EA, Comstock CE, Lee CH et al (2013) ACR BI-RADS\u00ae Magnetic Resonance Imaging. In: ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System, 5th edn. American College of Radiology, Reston","edition":"5"},{"key":"8042_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2307\/2532740","volume":"48","author":"B Lausen","year":"1992","unstructured":"Lausen B, Schumacher M (1992) Maximally selected rank statistics. Biometrics 48:73. https:\/\/doi.org\/10.2307\/2532740","journal-title":"Biometrics"},{"key":"8042_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239\u2013241. https:\/\/doi.org\/10.1093\/biomet\/69.1.239","journal-title":"Biometrika"},{"key":"8042_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2307\/2337123","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515. https:\/\/doi.org\/10.2307\/2337123","journal-title":"Biometrika"},{"key":"8042_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-016-0742-0","volume":"18","author":"CE Loo","year":"2016","unstructured":"Loo CE, Rigter LS, Pengel KE et al (2016) Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer. Breast Cancer Res 18:1\u201312. https:\/\/doi.org\/10.1186\/s13058-016-0742-0","journal-title":"Breast Cancer Res"},{"key":"8042_CR18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3348\/kjr.2015.16.5.986","volume":"16","author":"ES Ko","year":"2015","unstructured":"Ko ES, Han H, Han BK et al (2015) Prognostic significance of a complete response on breast MRI in patients who received neoadjuvant chemotherapy according to the molecular subtype. Korean J Radiol 16:986\u2013996. https:\/\/doi.org\/10.3348\/kjr.2015.16.5.986","journal-title":"Korean J Radiol"},{"key":"8042_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.rx.2012.10.004","volume":"56","author":"S Cruz Ciria","year":"2014","unstructured":"Cruz Ciria S, Jim\u00e9nez Arag\u00f3n F, Garc\u00eda Mur C et al (2014) Magnetic resonance imaging in breast cancer treated with neoadjuvant chemotherapy: radiologic-pathologic correlation of the response and disease-free survival depending on molecular subtype. Radiologia 56:524\u2013532. https:\/\/doi.org\/10.1016\/j.rx.2012.10.004","journal-title":"Radiologia"},{"key":"8042_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-018-1091-y","volume":"21","author":"SP Gampenrieder","year":"2019","unstructured":"Gampenrieder SP, Peer A, Weismann C et al (2019) Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). Breast Cancer Res 21:1\u201311. https:\/\/doi.org\/10.1186\/s13058-018-1091-y","journal-title":"Breast Cancer Res"},{"key":"8042_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-017-4254-0","volume":"164","author":"MS van Ramshorst","year":"2017","unstructured":"van Ramshorst MS, Loo CE, Groen EJ et al (2017) MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 164:99\u2013106. https:\/\/doi.org\/10.1007\/s10549-017-4254-0","journal-title":"Breast Cancer Res Treat"},{"key":"8042_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1148\/radiol.2015150013","volume":"279","author":"NM Hylton","year":"2016","unstructured":"Hylton NM, Gatsonis CA, Rosen MA et al (2016) Neoadjuvant chemotherapy for breast cancer: functional tumor volume by MR imaging predicts recurrence-free survival-results from the ACRIN 6657\/CALGB 150007 I-SPY 1 TRIAL. Radiology 279:44\u201355. https:\/\/doi.org\/10.1148\/radiol.2015150013","journal-title":"Radiology"},{"key":"8042_CR23","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer J-U et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30:1796\u20131804. https:\/\/doi.org\/10.1200\/JCO.2011.38.8595","journal-title":"J Clin Oncol"},{"key":"8042_CR24","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1245\/s10434-015-4404-8","volume":"22","author":"P Cortazar","year":"2015","unstructured":"Cortazar P, Geyer CE (2015) Pathological complete response in neoadjuvant treatment of breast cancer. Ann Surg Oncol 22:1441\u20131446. https:\/\/doi.org\/10.1245\/s10434-015-4404-8","journal-title":"Ann Surg Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08042-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08042-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08042-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T12:11:22Z","timestamp":1636719082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08042-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8042"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08042-1","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"8 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Almir Bitencourt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in a different scientific context (doi: 10.1016\/j.ejrad.2019.108701), while the prior report evaluated only tumor response to neoadjuvant chemotherapy, the current study focused on survival analyses, which were not previously available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Retrospective\u2022 Observational\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}